Taiwan FDA registration da18b373a688adc1beab8e012d0bdab7
“CIMA” BiVisc Sodium Hyaluronate/Sodium Chondroitin Sulfate Ophthalmic Viscosurgical Device
TW: “西瑪”雙維視人工眼內黏彈性溶液
Taiwan·Risk Class 3·MD·CIMA Technology Inc.·Registered Aug 25, 2020 – Aug 25, 2025ExpiredRegistration details
- Analysis ID
- da18b373a688adc1beab8e012d0bdab7
- License Form
- Ministry of Health Medical Device Import No. 033897
- Customs Code
- DHA05603389707
Company information
- Manufacturer
- CIMA Technology Inc.
- Manufacturer Country
- United States
- Authorized Representative
- COSMOS BIO, INC.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- M Ophthalmic devices
- Product Type (Level 2)
- M4275 Liquid for intraocular filling
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Aug 25, 2020
- Expiry Date
- Aug 25, 2025
About this record
Access comprehensive regulatory information for “CIMA” BiVisc Sodium Hyaluronate/Sodium Chondroitin Sulfate Ophthalmic Viscosurgical Device in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number da18b373a688adc1beab8e012d0bdab7 and manufactured by CIMA Technology Inc.. The authorized representative in Taiwan is COSMOS BIO, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices